[Current data concerning neoadjuvant chemotherapy]

MeSH terms

• Antibiotics, Antineoplastic / administration & dosage
• Antibiotics, Antineoplastic / therapeutic use
• Antineoplastic Agents / administration & dosage
• Antineoplastic Agents / therapeutic use
• Antineoplastic Agents, Alkylating / administration & dosage
• Antineoplastic Agents, Alkylating / therapeutic use
• Antineoplastic Agents, Phytogenic / administration & dosage
• Antineoplastic Agents, Phytogenic / therapeutic use
• Antineoplastic Combined Chemotherapy Protocols / administration & dosage
• Antineoplastic Combined Chemotherapy Protocols / therapeutic use
• Carboplatin / administration & dosage
• Carboplatin / therapeutic use
• Carcinoma, Non-Small-Cell Lung / drug therapy*
• Carcinoma, Non-Small-Cell Lung / mortality
• Carcinoma, Non-Small-Cell Lung / pathology
• Carcinoma, Non-Small-Cell Lung / radiotherapy
• Carcinoma, Non-Small-Cell Lung / surgery
• Chemotherapy, Adjuvant
• Cisplatin / administration & dosage
• Cisplatin / therapeutic use
• Etoposide / administration & dosage
• Etoposide / therapeutic use
• Humans
• Ifosfamide / administration & dosage
• Ifosfamide / therapeutic use
• Lung / pathology
• Lung Neoplasms / drug therapy*
• Lung Neoplasms / mortality
• Lung Neoplasms / pathology
• Lung Neoplasms / radiotherapy
• Lung Neoplasms / surgery
• Mitomycin / administration & dosage
• Mitomycin / therapeutic use
• Neoadjuvant Therapy*
• Neoplasm Staging
• Paclitaxel / administration & dosage
• Paclitaxel / therapeutic use
• Radiotherapy Dosage
• Radiotherapy, Adjuvant
• Randomized Controlled Trials as Topic
• Risk
• Time Factors